PDB Reference: PAPS-bound S. aureus PPAT, 3f3m, r3f3msf. Bacterial phosphopantetheine adenylyltransferase (PPAT) catalyzes the penultimate step in the coenzyme A (CoA) biosynthetic pathway. It catalyzes the reversible transfer of an adenylyl group from ATP to 4 0 -phosphopantetheine (Ppant) to form dephospho-CoA (dPCoA) and pyrophosphate. Previous structural studies have revealed how several ligands are recognized by bacterial PPATs. ATP, ADP, Ppant and dPCoA bind to the same binding site in a highly similar manner, while CoA binds to a partially overlapping site in a different mode. To provide further structural insights into ligand binding, the crystal structure of Staphylococcus aureus PPAT was solved in a binary complex with 3 0 -phosphoadenosine 5 0 -phosphosulfate (PAPS). This study unexpectedly revealed a new mode of ligand binding to PPAT, thus providing potentially useful information for structure-based discovery of inhibitors of bacterial PPATs.
Introduction
Coenzyme A (CoA) is an essential cofactor in numerous biosynthetic, degradative and energy-yielding metabolic pathways and is required in several key reactions in intermediary metabolism (Leonardi et al., 2005; Geerlof et al., 1999) . In bacteria, it is synthesized in five steps from pantothenate (vitamin B 5 ), cysteine and ATP (Robishaw & Neely, 1985) . Phosphopantetheine adenylyltransferase (PPAT), a member of the nucleotidyltransferase superfamily (Bork et al., 1995) , catalyzes the penultimate step in this biosynthetic pathway: the reversible transfer of an adenylyl group from ATP to 4 0 -phosphopantetheine (Ppant), yielding dephospho-CoA (dPCoA) and pyrophosphate (Izard & Geerlof, 1999) . In mammals, PPAT and dephospho-CoA kinase occur as a bifunctional enzyme called CoA synthase (Aghajanian & Worrall, 2002) . Bacterial PPATs and mammalian PPATs are highly dissimilar in primary sequence, thus making the bacterial PPATs an attractive target for the discovery of antibacterials.
Escherichia coli PPAT has been the target of extensive structural studies. Its structures in complex with dPCoA (Izard & Geerlof, 1999) , ATP (Izard, 2002) , Ppant (Izard, 2002) and CoA (Izard, 2003) have been reported. It is a homohexamer with 32 point-group symmetry. Only one trimer within the E. coli PPAT hexamer binds Ppant (Izard, 2002) or dPCoA (Izard & Geerlof, 1999) , whereas both trimers bind ATP (Izard, 2002) . Superposition of the bound adenylyl moieties of dPCoA and ATP in E. coli PPAT suggests an in-line displacement mechanism involving nucleophilic attack by Ppant on the -phosphate of ATP (Izard & Geerlof, 1999; Izard, 2002) . The conserved His18 of the TXGH sequence motif in E. coli PPAT plays an essential role in stabilizing the pentacovalent transition state, while Thr10 and Lys42 have been shown to orient the nucleophile of Ppant for attack on the -phosphate of ATP (Izard, 2002) . The structure of E. coli PPAT bound to CoA, a feedback regulator, revealed that the binding of the adenylyl moiety of CoA does not overlap with the adenylyl-binding site of dPCoA (Izard, 2003) . The 3 0 -phosphate on the ribose is required for the binding of CoA in this novel conformation (Izard, 2003) . The structures of Mycobacterium tuberculosis PPAT in the apo form (Morris & Izard, 2004) , Thermus thermophilus PPAT in complex with Ppant (Takahashi et al., 2004) , and Bacillus subtilis PPAT in complex with ADP (Badger et al., 2005) have also been reported. Futhermore, the structures of an archaeal PPAT (PDB code 3do8; R. Zhang, R. Wu, R. Jedrzejczak & A. Joachimiak, unpublished work) and a mammalian bifunctional coenzyme A synthase covering the C-terminal third of PPAT and the whole dephospho-CoA kinase (PDB code 2f6r; Joint Center for Structural Genomics, unpublished work) have been solved.
Staphylococcus aureus, a Gram-positive pathogen, is a major cause of hospital-and community-acquired infections. The development of methicillin resistance and more recently vancomycin resistance in S. aureus poses a serious health problem. Based on the inhibitorbound structure of E. coli PPAT, a potent and specific inhibitor with an IC 50 of 6 nM against E. coli PPAT but no activity against porcine PPAT has been obtained (Zhao et al., 2003) . To aid in structure-based discovery of new antibacterial compounds against major human pathogens such as S. aureus, detailed structural information on the binding modes of different ligands to the PPAT active site is desirable. In this study, we have solved the crystal structure of S. aureus PPAT as a binary complex with 3 0 -phosphoadenosine 5 0 -phosphosulfate (PAPS). This represents the first structure of PPAT complexed with PAPS. The PAPS-binding site overlaps with that of ATP, but their binding modes are distinct from each other. Thus, our structural study has unexpectedly revealed a new mode of ligand binding to PPAT, thus providing potentially useful information for the structure-based discovery of new antibacterial agents against PPATs.
Materials and methods

Protein expression, purification and crystallization
The coaD gene (SA_0973) encoding S. aureus PPAT was cloned into the expression vector pET-21a(+) (Novagen) using the NdeI/ XhoI sites. This vector construction adds an eight-residue tag (LE-HHHHHH) to the C-terminus of the gene product to facilitate protein purification. The protein was overexpressed in E. coli C41 (DE3) cells using Luria-Bertani culture medium. Following growth to mid-log phase at 310 K, protein expression was induced with 1 mM IPTG and the cells were incubated for an additional 18 h at 291 K. The cells were then lysed by sonication in lysis buffer (20 mM Tris-HCl pH 7.9 and 500 mM NaCl) containing 50 mM imidazole. Following centrifugation at 3800g for 60 min, the supernatant was applied onto a nickel-nitrilotriacetic acid-agarose affinity-chromatography column (Qiagen). The protein was eluted with buffer A containing 500 mM imidazole. The supernatant was applied onto a HiLoad XK-16 Superdex 200 prep-grade column (GE Healthcare) previously equilibrated with buffer A (50 mM Tris-HCl pH 8.0 containing 100 mM NaCl). Finally, the purified enzyme was concentrated to 26 mg ml À1 using a YM10 ultrafiltration membrane (Amicon) and stored at 203 K. S. aureus PPAT was crystallized by the hanging-drop vapour-diffusion method at 297 K by mixing equal volumes (2 ml each) of protein solution (26 mg ml À1 in buffer A) and reservoir solution (100 mM imidazole pH 8.0, 0.9-1.2 M potassium/sodium tartrate and 0.2 M NaCl). The crystals grew to approximate dimensions of 0.2 Â 0.2 Â 0.1 mm within a few days.
X-ray data collection and structure determination
Crystals were frozen using a cryoprotectant solution consisting of 20%(w/v) polyethylene glycol 400 in the crystallization mother liquor. X-ray diffraction data were collected at 100 K on an Area Detector Systems Corporation Quantum 4R CCD detector at the experimental station BL-18B of Photon Factory, Japan. For each image, the crystal was rotated by 1 . The raw data were processed and scaled using the HKL-2000 program suite (Otwinowski & Minor, 1997) . Table 1 summarizes the statistics of data collection. The crystal was indexed in space group P6 3 22, with unit-cell parameters a = b = 66.89, c = 124.14 Å , = = 90, = 120 (Table 1) . A monomer is present in the asymmetric unit, giving a crystal volume per protein mass (V M ) of 2.06 Å 3 Da À1 and a solvent content of 40.4%.
The structure was solved by the molecular-replacement method using the monomer model of E. coli PPAT (PDB code 1b6t; Izard & Geerlof, 1999) . A cross-rotational search followed by a translational search was performed using the program CNS (Brü nger et al., 1998; Brunger, 2007 jF obs j À jF calc j = P hkl jF obs j; R free is calculated for a randomly chosen set ($5%) of reflections which were not used for structure refinement and R work is calculated for the remaining reflections.
Figure 1
Stereo ribbon diagram of S. aureus PPAT monomer. PAPS bound in the active site is shown as a stick model. using the program O (Jones et al., 1991) . The model was refined by minimizing the maximum-likelihood target function on amplitudes using the program CNS (Brü nger et al., 1998; Brunger, 2007) , including bulk-solvent correction. Several rounds of model building, simulated annealing, positional refinement and individual B-factor refinement were performed. The model has reasonable stereochemistry as evaluated using the program MolProbity (Davis et al., 2007) . Refinement statistics are summarized in Table 1 .
Results and discussion
Monomer and hexamer structures
We have determined the crystal structure of S. aureus PPAT in complex with PAPS at 2.40 Å resolution. The refined model includes residues 2-39 and 45-160 of one PPAT monomer in the asymmetric unit. The N-terminal methionine, an eight-residue fusion tag at the C-terminus and residues 40-44 of the recombinant enzyme are presumably disordered in the crystal. The monomer adopts the dinucleotide-binding fold (or the canonical Rossmann fold; Rossmann et al., 1975) . Its core contains a five-stranded parallel -sheet arranged in the order 3-2-1-4-5, which is packed on one side by four -helices (1, 2, 5 and 6) and on the other side by two -helices (3 and 4) ( Fig. 1) . S. aureus PPAT is hexameric and displays 32 symmetry like other bacterial PPATs (Izard & Geerlof, 1999; Izard, 2002 Izard, , 2003 Morris & Izard, 2004; Takahashi et al., 2004; Badger et al., 2005) . All six subunits of S. aureus PPAT are bound with PAPS. This is similar to the structures of T. thermophilus PPAT in complex with Ppant (Takahashi et al., 2004) and B. subtilis PPAT in complex with ADP (Badger et al., 2005) . In contrast, in the E. coli PPAT structures Ppant and dPCoA were bound in only one of the two trimeric units (Izard & Geerlof, 1999; Izard, 2002) . A structural comparison of S. aureus PPAT with mammalian PPATs is not possible because little structural information is available on mammalian PPATs apart from the C-terminal third of mouse PPAT (PDB code 2f6r; Joint Center for Structural Genomics, unpublished work). 
Figure 3
Stereoview of the active site around the bound PAPS.
Figure 2
F o À F c OMIT electron-density map of PAPS contoured at the 2.5 level. The mean B factor of PAPS (40.8 Å 2 ) is slightly higher than that of the protein atoms, suggesting that the occupancy of PAPS is slightly lower than one. When the occupancy of PAPS is fixed at 0.8, its B factor (30.9 Å 2 ) is comparable to that of the protein atoms (28.6 Å 2 ).
interpreted as PAPS (Fig. 2) . Fitting with ATP was much less satisfactory. Apparently, endogenous PAPS inside the E. coli cells bound to the recombinant S. aureus PPAT. PAPS is a co-substrate for sulfuryl transferases and is a ubiquitous intracellular cofactor (Klaassen & Boles, 1997) . In the PAPS complex of S. aureus PPAT, Arg89 and Tyr99 interact with the sulfate moiety of the 5 0 -phosphosulfate group of PAPS, while Ser11 interacts with the phosphate moiety of the 5 0 -phosphosulfate group. Ser129 and Ser131 interact with the 3 0 -phospho group. His19, Arg92 and Ser130 interact with ribose ( Fig. 3 and Table 2 ). All these residues are well conserved in bacterial PPATs (Fig. 4) . In conclusion, PAPS is bound in the ATPbinding pocket of S. aureus PPAT in a mode that is distinct from those of either ATP (Izard, 2002) or the adenylyl moiety of dPCoA (Izard & Geerlof, 1999) bound to E. coli PPAT (Fig. 5) . The new ligandbinding mode revealed in this study should be useful in the design of PPAT inhibitors because PAPS may be a potential inhibitor of bacterial PPATs.
We thank the beamline staff for assistance during data collection at the BL-18B experimental station of Photon Factory, Tsukuba, Japan. The distinct mode of PAPS (blue) binding to S. aureus PPAT. ATP (yellow, 1gn8 chain B) and dPCoA (orange, 1b6t chain B) bound in E. coli PPAT (Izard & Geerlof, 1999; Izard, 2002) are positioned in the active site of S. aureus PPAT by superimposing PPAT monomer structures. With the exception of Fig. 4 , all figures were produced using PyMOL (http://www.pymol.org).
Figure 4
Alignment of bacterial PPAT amino-acid sequences. SA, Staphylococcus aureus (SWISS-PROT accession code P63819); EF, Enterococcus faecalis (Q831P9); TM, Thermotoga maritima (Q9WZK0); EC, Escherichia coli (P0A6I6); MT, Mycobacterium tuberculosis (P0A530); TT, Thermus thermophilus (Q72K87). Strictly conserved residues and semi-conserved residues are coloured cyan and yellow, respectively. The TXGH sequence motif is enclosed in a red box. The residues of S. aureus PPAT that interact with PAPS are indicated by blue inverted triangles above the sequences. Cylinders and arrows above the sequences denote -helices and -strands, respectively. Secondary-structure elements are indicated for the PAPS complex of S. aureus PPAT. This figure was produced using ClustalX (Thompson et al., 1997) and GeneDoc (http:// www.nrbsc.org/).
